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Abstract
Background: The etiology of persistent lung inflammation in preterm infants with chronic lung disease of prematurity (CLD)
is poorly characterized, hampering efforts to stratify prognosis and treatment. Airway macrophages are important innate
immune cells with roles in both the induction and resolution of tissue inflammation.
Objectives: To investigate airway innate immune cellular phenotypes in preterm infants with respiratory distress syndrome
(RDS) or CLD.
Methods: Bronchoalveolar lavage (BAL) fluid was obtained from term and preterm infants requiring mechanical ventilation.
BAL cells were phenotyped by flow cytometry.
Results: Preterm birth was associated with an increase in the proportion of non-classical CD14+/CD16+ monocytes on the
day of delivery (58.965.8% of total mononuclear cells in preterm vs 33.066.1% in term infants, p = 0.02). Infants with RDS
were born with significantly more CD36+ macrophages compared with the CLD group (70.365.3% in RDS vs 37.668.9% in
control, p = 0.02). At day 3, infants born at a low gestational age are more likely to have greater numbers of CD14+
mononuclear phagocytes in the airway (p = 0.03), but fewer of these cells are functionally polarized as assessed by HLA-DR
(p = 0.05) or CD36 (p = 0.05) positivity, suggesting increased recruitment of monocytes or a failure to mature these cells in
the lung.
Conclusions: These findings suggest that macrophage polarization may be affected by gestational maturity, that more
immature macrophage phenotypes may be associated with the progression of RDS to CLD and that phenotyping
mononuclear cells in BAL could predict disease outcome.
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Introduction
Chronic lung disease (CLD) of prematurity, often also called
bronchopulmonary dysplasia (BPD), is a significant complication
of preterm birth, leading to increased respiratory symptoms,
repeated hospital admissions and abnormal long term lung
physiology resulting in great economic cost and markedly
increased parental burden. The pathogenesis of CLD is linked
to a number of clinical factors, including prematurity, mechanical
ventilation, oxygen therapy and post- and ante-natal infection all
of which help to initiate or sustain an inflammatory process in the
preterm lung. Persistent airway neutrophilia and elevated levels of
neutrophil chemoattractants, including CXCL8, in broncho-
alveolar lavage (BAL) fluid, are associated with the development
of CLD in preterm infants [1]. Inappropriate suppression of
neutrophil apoptosis is also associated with progression to CLD in
preterm infants [2]. Macrophages play important roles in inducing
and resolving neutrophilic inflammation but their role in CLD is
not well defined, particularly in view of the difficulty in acquiring
samples from significantly preterm infants. Unresolved questions
are how the preterm infant lung orchestrates this inflammatory
response and the role of macrophage populations in this process.
The limitations in our understanding of lung injury pathogenesis
in preterm infants limits our ability to predict which infants may go
onto to experience dysregulated inflammation and develop CLD,
and also our ability to develop targeted interventions to improve
outcome.
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e103059
Our previous results have demonstrated increased numbers of
macrophages in infants with respiratory distress syndrome (RDS),
a condition associated with more effective resolution of inflam-
mation and better clinical outcome than CLD, which is
characterized by chronic distal airway inflammation and poor
lung function. This observation, together with the known roles of
macrophages, suggests macrophages may regulate inflammatory
responses in the preterm lung [2]. This could derive from a
number of the known roles of differentiated macrophages, alone or
in combination, including the surface expression of death
receptors ligands that may initiate apoptosis in vivo, the
production of anti-inflammatory cytokines such as IL-10, or via
efferocytosis and cell clearance [3,4,5,6,7].
These data led us to hypothesise that the relative abundance of
macrophages in the preterm lung, and their differentiation status
and activation phenotypes, may be associated with either the
resolution of RDS or the progression to CLD. In this study,
macrophages in BAL fluid samples from preterm infants
retrospectively diagnosed with RDS or CLD, and from infants
born at term, were phenotyped by flow cytometry, and the
relationships between macrophage phenotype, disease severity and
gestational age were examined.
Materials and Methods
Patients were recruited in the regional neonatal intensive care
unit at the University Hospital of Wales, Cardiff. The study was
approved by the Cardiff and Vale NHS Trust Research and
Development Committee and the South East Wales Research and
Ethics Committee (05/WSE04/85). Written informed consent was
obtained from the parents.
Two groups of infants were recruited: 1) Preterm infants (#32
weeks gestation) who required mechanical ventilation for RDS
defined by clinical and radiological features, were recruited within
the first 12 hours of life (n = 18). This group was later subdivided
into those infants who went on to develop CLD (oxygen
dependence at 36 corrected gestation, n= 11) and those infants
where RDS resolved (RDS group, n= 7).
2) Term control infants (.37 weeks gestation, n = 4) who
required mechanical ventilation for non-respiratory reasons (for
example infants ventilated peri-operatively for gastroschisis).
Bronchoalveolar lavage (BAL) was performed within 24 hours
of birth on ventilated infants as previously described [8,9]. Briefly,
with the infant lying supine and the head turned to the left, a size 6
French Gauge (FG) catheter was introduced down the endotra-
cheal tube until resistance was felt, then 1 ml/kg of 0.9% saline
(maximum of 2 ml) was instilled via the catheter. The catheter was
connected to 8–12 kPa of suction pressure and the lavage fluid
collected in a suction trap as the catheter was withdrawn. The
procedure was repeated and the lavages pooled for immediate
analysis.
Cellular pellets were separated by centrifugation and mucus
disrupted by treatment with dithiothreitol (DTT). DTT had no
effect on antigen detection by any antibody used (data not shown).
A cell count was performed and cytospins prepared (Shandon,
Thermo Fisher, Loughborough, UK) for morphological analysis.
Slides were air dried, fixed in methanol and stained with Giemsa
based stains (Diff-Quik, Reagena, Toivala, Finland).
Flow cytometry
Cells were washed to remove DTT and stained with the
indicated antibodies: HLA-DR-APC (BD Bioscience, Oxford,
UK), CD16-PE, CD36-PE, CD15-APC (Biolegend, San Diego,
CA) and CD14-biotin (Southern Biotech, Birmingham, AL).
Staining combinations were as follows: CD15, CD14/CD16,
CD14/HLA-DR/CD36. Streptavidin-PE-Cy5.5 tandem conju-
gate (eBioscience) was used as a secondary reagent to detect
biotinylated primary antibodies. Following staining, samples were
immediately analysed by flow cytometry (FACScalibur, Becton
Dickinson, Oxford, UK).
Neutrophils were identified as CD15+ events. Cells of the
monocyte/macrophage lineage were identified as CD14+. CD15+
neutrophils were CD14 negative, allowing distinction of these two
cell types [10]. CD14+/16++ non-classical monocytes were
identified as highly CD16 positive CD14+ cells. Forward scatter
(FSC) and side scatter (SSC) profiles were also examined. Flow
cytometry data were analysed using FlowJo (Tree Star Inc,
Ashland, OR).
Cytokine bead array (CBA) analysis
Cytokines were measured in cell-free BAL using a CBA custom
flex set multiplexed assay (BD Biosciences). Antibodies to IL-1b,
CXCL8, CCL3, CCL4 (pro-inflammatory indicators) and IL-10
(anti-inflammatory indicator) were used and samples analyzed by
FACS array (BD Biosciences).
Statistical analysis
Data were analysed by Mann Whitney test and regression
analysis by linear regression (GraphPad Prism, La Jolla, CA) as
defined in the figure legend.
Results
Characteristics of the 22 infants included in this study are shown
in Table 1. The cellularity of BAL was studied by flow cytometry
using antibodies to CD15, CD14, CD16, CD36 and HLA-DR.
Mean6SEM numbers of cells (6106) recovered/ml were
1.0260.29 (term), 4.1761.78 (RDS) and 1.4260.2.86 (CLD).
The numbers of neutrophils (CD15+) recovered were significantly
higher in preterm infants compared with term infants within
24 hours of birth, both as a percentage of all cells and as absolute
numbers (figure 1A, B). CD14, a co-receptor for TLR signaling, is
expressed by both airway macrophages and monocytes [11].
CD14+ cells were greater in both percentage and absolute number
(figure 1C, D) in some preterm compared with term infants,
although differences were not statistically significant. Figure 2
shows flow cytometry plots of samples stained with antibodies to
CD15, CD14, CD16, CD36, HLA-DR and respective isotype
controls (panels A–E). A box is drawn around CD14+/CD16++
cells to illustrate gating strategy used (figure 2F). Since CD14 is
downregulated as macrophages mature [3], macrophage numbers
were assessed both by CD14 and HLA-DR or CD36 co-
expression and as HLA-DR/CD36 single stained events, the
latter to account for CD14 low macrophages (figure 2D–E & G–
H). Cells single stained for HLA-DR or CD36 (figure 2G, H)
appear in the same region as cells dual positive for CD14+ and
either HLA-DR (figure 2I) or CD36 (figure 2J). Since both gating
strategies identified cells in the same FSC/SSC region and
numbers of cells were comparable for both approaches, a single
approach of CD14/CD36 or CD14/HLA-DR positivity was
followed for the remaining analysis. HLA-DR2/CD362 events
were identified in a SSC/FSC low region (indicating cells are
smaller and less granular) while HLA-DR+/CD36+ events were
characterized as mid FSC and mid-high SSC (indicating cells are
larger and more granular, figure 2K–N). HLA-DR+/CD142
events were gated as dendritic cells, although very low numbers
were identified in all samples (data not shown).
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Elevated numbers of non-classical monocytes (CD14+/16++) are
associated with inflammation and injury [12] and are also a source
of alveolar macrophages [13]. As a proportion of CD14+ cells, the
proportion of CD14+/16++ cells was significantly greater in
preterm infants compared with term infants at on the within
24 hours of birth (figure 3A). Although a trend for increased
absolute number of CD14+/16++ in preterms is seen, these data do
not reach statistical significance (figure 3B). As a proportion of all
CD14+ cells, there is no significant difference between either HLA-
DR+ or CD36+ macrophages in preterm or term samples
(figure 3C, D).
To study the relationship between gestational age and the
myeloid cell populations of the lung in the days following birth,
some ventilated infants underwent ongoing sampling. Day 3 was
chosen for further study as it allows observations to be made on
recruitment and maturation of airway cells over a biologically
relevant timescale, but which precedes extubation for many of the
infants in this study. On day 3, the proportion of CD14+ cells was
greater at low gestational ages, reaching statistical significance
when analysing absolute numbers (figure 4A, B). There was a
significant correlation between the proportion of CD14+ cells that
were also positive for HLA-DR or CD36, and gestational age
(figure 4C, D). To examine the relationship between the presence
of neutrophils and macrophages in the immediate peri-natal
period, absolute numbers of these cell populations were correlated.
Absolute numbers of both CD14+/CD36+ and CD14+/HLA-DR+
macrophages were significantly correlated with numbers of
neutrophils in BAL (figure 5A, B). Cytokines were also measured
in BAL from preterm subjects by CBA and significant correlations
were seen between absolute numbers of: CD15+ cells and CCL4
and IL-10; CD14+/CD16+ and CCL4; CD14/CD36+ and CCL3,
CCL4; CD14/HLA-DR+ and IL-1b, CXCL8, CCL4 and IL-10
(table 2). Individual correlations of cell number and cytokine
levels, where there is a statistically significant relationship, are
shown in figure 6 (A–H). Mean cytokine levels ranged from
50.2619.2 pg/ml for IL-10 to 14.563.5 ng/ml for CXCL8
(figure 6I).
Cytocentrifuge slides were made from BAL cells within
24 hours of birth and representative images are presented in
figure 7. In keeping with figure 1, term infants who were
ventilated for non-respiratory problems had few or no neutrophils
and low numbers of macrophages, but the latter cells had the
classical appearance of alveolar macrophages (figure 7A, B).
Infants with CLD (figure 7C, D) and RDS (figure 7E–H) had
more macrophages overall. A qualitative difference between
macrophages from CLD and RDS was also observed, with
macrophages isolated from RDS infants appearing larger and
more mature. Phenotypic analysis of cells in these patient groups
Figure 1. Preterm delivery is associated with increased neutrophils and monocyte–macrophages in the airway. Infants were ventilated
and lavaged within 24 hours of birth and cells were immediately stained with anti-CD14, anti-CD15 or matched isotype antibodies and analysed by
flow cytometry. Neutrophils (A, B) are defined as CD15+ events and macrophages (C, D) are defined as CD14+ve events and expressed as percent of
all cells (A, C) or as absolute numbers/ml lavage fluid (B, D). Statistical analyses were carried out by Mann Whitney test and compared samples
collected from pre-term (n= 12–16 of which RDS:CLD 6–8:8) to term (n = 4) infants.
doi:10.1371/journal.pone.0103059.g001
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indicated that, as a percentage of macrophages, RDS infants had a
higher percentage of CD36+ macrophages (figure 8B) yet the
overall proportion of macrophages was similar between the two
patient groups (data not shown). A trend for a greater proportion
of HLA-DR+ macrophages was also seen in RDS compared to
control groups but this was not statistically significant (figure 8A).
There was no significant difference in percent of CD14+/CD16+
cells in the BAL of CLD versus RDS infants (data not shown).
Discussion
CLD is a significant cause of morbidity and mortality in preterm
infants, with symptoms continuing into adulthood at a great
economic cost. Multiple factors occurring both pre- and post-
natally contribute to the development of CLD including infection,
ventilator induced lung injury, and a persistent inflammatory
response. Current therapeutic strategies are of limited benefit, and
mostly treat symptoms rather than the causative mechanisms,
Figure 2. Flow cytometry strategy for identifying functionally polarised macrophage populations in BALF. Infants were ventilated and
lavaged within 24 hours of birth and cells were stained with anti-CD15 (A), anti-CD14 (B), anti-CD16 (C), anti-HLADR (D), anti-CD36 (E) or matched
isotype antibodies and analysed by flow cytometry. Staining profiles showing isotype controls in blue and target antibody in red. CD14/CD16 staining
profile shown in F. Positively stained events are higlighted in FSC and SSC plots in blue for HLADR (G), CD36 (H), CD14/HLADR dual stained (I) and
CD14/CD36 dual stained (J). FSC/SSC profiles of CD14+ and: HLADR2 (K), HLADR+ (L), CD362 (M) and CD36+ (N) events. Plots illustrate representative
data from 3 individual subjects.
doi:10.1371/journal.pone.0103059.g002
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resulting in a significant and unmet need for novel and highly
targeted medicines. To begin to address this issue, we must
understand how normal cellular processes become dysregulated in
the preterm lung, identifying both the relevant cell populations
and the molecular events that lead to chronic inflammation and
lung injury.
As a phenotypically heterogeneous cell population, the effector
functions of alveolar macrophages vary with their differentiation
status and functional polarisation. More differentiated alveolar
Table 1. Patient information.
Preterm group Term controls
Number of Patients 18 4
Number of Samples 30 6
Median Gestational Age (range) 26+5 (23+4–31+2 wks) 38+1 (37+2–38+3 wks)
Median Birth Weight (range) 960 g (550–1920 g) 2730 g (2570–3000 g)
Male:Female 11:7 4:0
Vaginal:Caesarean delivery 10:8 1:3
RDS:CLD 7:11 -
At least 1 dose antenatal corticosteroids 14/18 (78%) 1/4 (25%)
Patent Ductus Arteriosus 14/18 (78%) 0/4 (0)%
Surfactant therapy (%) 18/18 (100%) 0/4 (0%)
Rupture of membranes .24 hours 4/18 (22%) 0/4 (0%)
Median days of ventilation (range) 18 (1–92 d) 3.5 (2–21 d)
doi:10.1371/journal.pone.0103059.t001
Figure 3. Preterm delivery is associated with increased non-classical macrophages in the airway. Infants were ventilated and lavaged
within 24 hours of birth and cells were stained with anti-CD14, anti-CD16, anti-CD36, anti-HLADR or matched isotype antibodies and analysed by flow
cytometry. Non-classical macrophages are defined as CD14+/CD16++ and expressed as percent of all macrophages (A) or absolute numbers of
CD14+/CD16++ cells/ml lavage (B). CD14+/HLA-DR+ and CD14+/CD36+ cells are expressed as percent of all macrophages (C, D). Statistical analyses
were carried out by Mann Whitney test and compared samples collected from pre-term (n= 10–12 of which CLD:RDS; 7–8:3–4) to term (n= 4) infants.
doi:10.1371/journal.pone.0103059.g003
Macrophage Phenotype in CLD of Prematurity
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macrophages are considered anti-inflammatory due to their
abilities to secrete anti-inflammatory factors and participate in
pathogen handling and efferocytosis [14]. We show preterm
infants with resolving inflammatory lung injury have greater
numbers of airway macrophages of a differentiated phenotype
than infants with progressive inflammatory disease. We also show
that prematurity is associated with increased populations of non-
classical, pro-inflammatory monocytes-macrophages in the lung
on the day of delivery. At day 3, we found infants born at a low
gestational age are more likely to have greater numbers of CD14+
mononuclear phagocytes in the airway but fewer of these cells are
functionally polarized, suggesting increased recruitment of mono-
cytes or a failure to mature these cells in the lung. These findings
suggest airway macrophage phenotype may be an important
determinant of clinical outcome in neonatal inflammatory lung
disease.
In humans, macrophages are thought mostly to differentiate
post-natally with very few macrophages populating the sterile
environment of the normal human lung at birth [15,16,17,18]. In
vivo studies show circulating monocytes appear from 20 weeks
gestation [19] and macrophages are recoverable from the lung
before birth [20], having matured under the influence of local
factors including alveolar type 1 cells, bronchial epithelium,
cytokines and surfactant [21]. Acquisition of secondary lysosomes
is dependent on breathing air, suggesting other maturation
processes do not occur until birth [22]. In rabbits, numbers of
macrophages increase shortly before birth, continuing throughout
the first month of life. Work using a murine lung explant model
demonstrated not only that macrophages were present in the fetal
lung but also that they were critical to lung immune responses
[23,24].
Macrophages containing apoptotic neutrophils have been
visualized in BAL from preterm infants, supporting a functional
role for these cells in the preterm infant lung [25]. Our current
data show that both preterm and term infants have populations of
macrophages in the lung at birth, as determined both by light
microscopy and by co-expression of CD14 with CD36 or HLA-
DR, presentational molecules with known immunoregulatory
functions. HLA-DR is an antigen presentation receptor expressed
on mature airway macrophages [26,27]. CD36 is a scavenger
Figure 4. Early delivery is associated with increased numbers of macrophages and decreased populations of cells with an anti-
inflammatory phenotype. Infants were ventilated and lavaged at 3 days of age and cells were stained with anti-CD14, anti-HLA-DR, anti-CD36 or
matched isotype antibodies and analysed by flow cytometry. Data are expressed as percentage (A) or absolute numbers (B) of CD14+ events. Cells
dual stained with CD14+/HLADR (C) or CD14+/CD36+ (D) are expressed as a percentage of all CD14+ events. Data are analysed by liner regression
(n = 9–11 of which CLD:RDS; 6–8:3) and show R square and p values.
doi:10.1371/journal.pone.0103059.g004
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receptor expressed by both monocytes and macrophages, appear-
ing at the peak of macrophage differentiation [28,29,30]. As well
as facilitating bacterial phagocytosis, CD36 expression is associ-
ated with a macrophage phenotype that is more likely to
efferocytose, and thus confers both a functional and anti-
inflammatory phenotype upon the macrophage, and has been
shown to play protective roles in inflammation [30,31]. Flow
cytometry data confirm these antigens as markers of differentia-
tion, where CD36/HLA-DR2 macrophages appear as FSC/SSC
low events, smaller and less granular cells, consistent with
immature macrophages. CD36/HLA-DR+ macrophages howev-
er, have a higher FSC/SSC profile, consistent with that of mature
tissue macrophages. Interestingly, preterm infants have a compa-
rable proportion of HLA-DR+ macrophages to term infants,
despite the developmental disadvantage of the former group,
perhaps suggesting these cells have roles in immune surveillance
and antigen presentation in utero. Other roles of macrophages in
the sterile environment of the newborn lung may include
‘housekeeping’ roles such as removal of cellular debris, clearance
of surfactant and remodeling and repair. Maintenance of
macrophages in a detuned state facilitates homeostasis whereas
inappropriate activation can arrest development (e.g BPD) and
can lead to acute lung injury (e.g ARDS). It may also be beneficial
to have immune defences already in place in anticipation of the
potentially threatening event of birth.
The origins of mature airway macrophages at birth are unclear.
They may be rapidly released from the pulmonary interstitial
compartment at the time of birth [15]. It is also likely that mature
airway macrophages can arise from the maturation of newly
recruited monocytes upon breathing air, however this may occur
over a number of days rather than the immediate perinatal period.
Macrophages have been detected at autopsy in the lungs of human
infants from 20 weeks gestation who died as a result of congenital
pneumonia, suggesting that a significant inflammatory response
Figure 5. Numbers of neutrophils in the airway correlate with numbers of mature macrophages. Infants were ventilated and lavaged
within 24 hours of birth and cells were stained with anti-CD15, anti-CD14, anti-HLA-DR, anti-CD36 or matched isotype antibodies and analysed by
flow cytometry. Data are expressed as absolute numbers of CD15+ events plotted against absolute numbers of CD14/CD36+ (A) or CD14/HLADR+ (B).
Data are analysed by liner regression (n = 11 of which CLD:RDS; 8:3) and show R square and p values.
doi:10.1371/journal.pone.0103059.g005
Macrophage Phenotype in CLD of Prematurity
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pre- or peri-natally may trigger monocyte migration and
macrophage maturation in vivo [16]. There is other evidence
that the lung can be primed even before birth, for example in
chorioamnionitis, which is associated with the development of
CLD and may also influence the phenotype of cell populations in
the lung [32,33]. The presence of 16S ribosomal RNA was
detected in some of the BAL samples (data not shown) but subject
numbers did not allow us to probe for a significant relationship
between infection and macrophage phenotype. It is also worth
noting that corticosteroid treatment is another potential influence
Figure 6. Cytokine levels correlate with cell type in preterm lavage. Preterm infants (CLD:RDS; 8:4) were ventilated and lavaged within
24 hours of birth and cells stained with combinations of anti-CD15 (A,B), anti-CD14(C–H), anti-CD16 (C), anti-CD36 (D), anti-HLA-DR (E–H), or matched
isotype antibodies and analysed by flow cytometry. Cytokine bead arrays were carried out on cell-free lavage and the following cytokines were
measured: IL-1b, CXCL8, CCL3, CCL4, and IL-10. Correlations of cytokine levels and absolute numbers of cells were analysed by linear regression and
significant correlations are shown above. Panel I shows mean6 SEM absolute cell number (million/ml, right axis) and mean6 cytokine levels [pg/ml,
left axis] for all samples.
doi:10.1371/journal.pone.0103059.g006
Macrophage Phenotype in CLD of Prematurity
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on cell maturation and function in utero, however, sample size and
differences in the type and duration of treatment meant that we
were unable to investigate a possible role for corticosteroids in this
study.
In adults following acute pulmonary inflammatory stress,
numbers of alveolar macrophages decrease and are replaced by
macrophages of a more immature phenotype, possibly by rapid
recruitment of monocytes from the vascular compartment [34]. In
our study, day 3 BAL shows an inverse correlation between
gestational age and CD14+ cells in the lung, yet infants of a low
gestational age have, as a proportion of these CD14+ cells, fewer
mature macrophages. These data may indicate a greater stimulus
for monocyte recruitment into the lung and/or a possible failure of
maturation in the more preterm individuals. This idea is in
accordance with studies that show decreased HLA-DR expression
on monocytes isolated from cord or venous blood from infants of a
low gestational age compared with less preterm infants [35,36],
suggesting that the process of monocyte maturation is ongoing
during gestation. Moreover, this phenomenon may continue into
childhood, since macrophage HLA-DR expression is greater in
children over compared to those under the age of two years [37].
Studies in mice have shown newly recruited peripheral blood
monocytes and not alveolar macrophages are responsible for later-
phase neutrophil migration to the lung following inflammatory
stimulus, indicating immature macrophages are more likely to
perpetuate on-going inflammation [38]. Thus very preterm infants
may have a failure in the ongoing maturation process of tissue
macrophages, which may in turn impair functional responses of
these cells and increase the susceptibility of preterm infants to
infection and inflammatory disease [17,39,40,41].
The importance of the mononuclear cell phenotype in the
context of inflammation has also been demonstrated in the form of
CD14+/CD16+ populations, also referred to as ‘non-classical’
monocytes [42]. CD14+/CD16+ monocytes are highly synthetic
cells that secrete pro-inflammatory cytokines and are a source of
alveolar macrophages in the mouse [43]. Residing in the marginal
pool, they rapidly extravasate into the tissue and become elevated
both in the circulation and at inflammatory sites during
inflammatory disease [12,44,45,46]. Increased numbers of non-
classical monocytes have been demonstrated in various inflamma-
tory diseases including chronic liver disease, and these cells have
an augmented inflammatory output both in vitro and in vivo [12].
Our data show significantly greater CD14+/CD16+ macrophages
in preterm infants compared to term infants on the day of delivery.
This difference may represent recruitment of increased numbers of
circulating CD14+/CD16+ monocytes although further studies
phenotyping peripheral blood monocytes to determine whether an
increase in the tissue pool of non-classical macrophages are
derived from greater numbers in the circulation, would be
required to corroborate this. Since non-classical monocytes are
capable of enhanced generation of pro-inflammatory cytokines, it
is possible that this population may contribute to the inflammation
observed in the lungs of preterm newborns.
We also examined the relationship between neutrophils, and
macrophages expressing HLA-DR or CD36, which as a significant
source of cytokines and chemokines may co-ordinate the
recruitment of other cells. A strong correlation between mature
macrophage and neutrophil numbers is seen. This could reflect a
role for one of these cell types in the recruitment of the other, or
simply that individual infants are more likely to globally recruit
cells than others. Our preliminary study of relationships between
BAL cytokine levels and different cell phenotypes suggests the
former explanation, where The former explanation is more
probable since CBA analysis of BAL also indicates a strong
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Figure 7. Morpholocial assessment of BAL cellularity. Infants were ventilated and lavaged within 24 hours of birth and cytocentrifuge slides
were prepared from BAL cells. Term infants (A,B) and infants who developed CLD (C,D) or RDS (E–H) were studied. Images were viewed under6400
(A,C,E) or61000 (B,D,E–H) lenses. Cell populations indicated as follows: m: macrophage, ec: epithelial cell, n: neutrophil Scale bar indicates 0–7.5 um
in length.
doi:10.1371/journal.pone.0103059.g007
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correlation between individual cell populations and cytokine levels
at preterm birth, where in particular, HLA-DR+ macrophages are
associated with IL-1b, CXCL-8, CCL4 and IL-10 levels,
suggesting these cell types may be an important source of these
cytokines [47]. HLA-DR expression correlates with increased
cytokine production in monocytes [48] and in our study, the
association with cytokine generation may reflect a more mature
functionality of this macrophage population. Although CD36+ and
HLA-DR+ macrophages represent mature phenotypes, they may
differ in their cytokine output in the tissue. CD36+ macrophages
are able to take part in efferocytosis, which is known to be
associated with the production of anti-inflammatory cytokines by
macrophages [28,49,50]. This may in part explain why the
number of CD36+ macrophages does not correlate with pro-
inflammatory cytokines such as IL-1b and CXCL8. Unexpectedly,
CD36+ macrophage numbers are not associated with IL-10 in this
study, a key macrophage anti-inflammatory cytokine.
We show that infants with progressive inflammatory disease
(CLD) have fewer mature airway macrophages in the immediate
peri-natal period compared to infants with resolving disease (RDS)
suggesting phenotyping macrophages in ventilated infants may be
a predictive marker of disease outcome allowing the stratification
of treatment based on risk. Based on these findings, we speculate
that the presence of mature airway macrophages may drive
inflammation resolution, or indeed that the process of inflamma-
tion resolution may drive macrophage maturity. In support of this,
we have previously shown an increase in total macrophages in
BAL from infants with RDS compared to those with CLD, as
determined morphologically [2]. Morphological data from this
current study support the presence of mature macrophages in the
lung of infants with RDS, illustrated by the appearance of large
mononucleated cells with a high cytoplasm to nucleus ratio.
CD36 facilitates efferocytosis by macrophages, driving the
resolution of inflammation [30,51], and may in the context of
neonatal inflammation, contribute to the clearance of tissue
neutrophils and therefore promote inflammation resolution.
Increased CD36+ macrophages in RDS infants compared to
CLD infants may reflect the greater need for efferocytosis due to
the increased neutrophil burden in the RDS lung [2]. In addition,
it is conceivable that macrophages of a more immature phenotype
may drive ongoing inflammation in the tissue, both via the
synthesis of chemokines and enhanced activation status. A role for
alveolar macrophages in disease has been established by others,
although the maturity status of macrophages in these studies was
not explored. Fetal lung macrophages contribute to the develop-
ment of CLD/BPD in mouse models by generating a lung
inflammatory response [24] and the presence of CD68+ macro-
phages is associated with Wilson-Mikity syndrome in preterm
infants [52]. A study exploring HLA-DR expression on circulating
monocytes in neonates showed decreased expression of HLA-DR
in preterm infants with inflammatory lung disease compared to
healthy preterm infants [53], suggesting that HLA-DR may be an
important factor in the development of CLD, although differences
were not statistically significant in our study. Proving the cause and
effect relationship between statistically significant yet small
differences in cell types was beyond the scope of this study, and
future work correlating macrophage phenotype with cellular
function ex vivo would be of great benefit.
In summary, we have demonstrated an association between
macrophage phenotypes and disease progression in the context of
chronic lung disease of prematurity. Not only do these findings
associate macrophage phenotype with disease outcome in the
context of neonatal lung disease, but also suggest new therapeutic
possibilities focusing on delivering treatments to mature macro-
phage populations in the lung in preterm infants at risk of CLD.
Furthermore, ex vivo phenotyping studies of ventilated preterm
babies at birth may allow the stratification of risk in this patient
group and enable treatment strategies to be tailored according to
likely disease prognosis. These findings may help develop new
therapeutic strategies focused on macrophage maturation in this
clinically important disease.
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